| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 15.89 Billion | USD 27.87 Billion | 6.44% | 2023 |
According to a report from Zion Market Research, the global Cardiac Monitoring & Cardiac Rhythm Management Devices Market was valued at USD 15.89 Billion in 2023 and is projected to hit USD 27.87 Billion by 2032, with a compound annual growth rate (CAGR) of 6.44% during the forecast period 2024-2032. This report explores market strengths, weakness, opportunities, and threats. It also provides valuable insights into the market's growth drivers, challenges, and the future prospects that may emerge in the Cardiac Monitoring & Cardiac Rhythm Management Devices industry over the next decade.
The cardiac monitoring & cardiac rhythm management devices include devices that basically help the patients to manage and treat arrhythmia-related diseases. The primary focus of cardiac monitoring in the ED setting is on monitoring arrhythmias, myocardial infarction, and QT-interval monitoring. It is a method for diagnosis that is noninvasive.
As part of electrocardiography, monitoring of the heart rate can be carried out, but it can also be easily assessed with specialized heart rate monitors. Performers of different forms of physical activity use these heart rate monitors to a significant degree.
The major factors responsible for the growth of the global cardiac monitoring & cardiac rhythm management devices market include the growing frequency of cardiovascular diseases, increasing consciousness regarding heart monitoring in patients, technological improvements, and an increase in private organizational nursing and home care.
The global cardiac monitoring & cardiac rhythm management devices market can be segmented based on cardiac monitoring devices, cardiac rhythm management devices, end-user, and regions. The cardiac monitoring devices segment of the market is divided into implantable loop recorders, ECG devices, event monitors, and cardiac output monitoring. The event monitors segment of the market is sub-segmented into event monitors, by technology, and event monitors, by type. The event monitors, by technology segment of the market, are diversified into manual event monitors and auto detects event monitors. The event monitors, by type segment of the market, are classified into post-symptom and pre-symptom.
The ECG Devices segment of the market is divided into ECG devices, by lead type and ECG devices, by type. The ECG devices, by lead type segment of the market is sub-segmented into 3 to 6-lead ECG devices, single-lead ECG devices, 12-lead ECG devices, and others. The ECG devices, by type segments of the market, are classified into stress ECG, resting ECG, and Holter monitor. The cardiac rhythm management devices segment of the cardiac monitoring & cardiac rhythm management devices market is sub-segmented into defibrillators, cardiac resynchronization therapy devices, and pacemakers. The defibrillators segment of the market is classified into manual external defibrillators, implantable defibrillators, automated external defibrillators, and external defibrillators. The end-user segment of the market is divided into hospitals, home & ambulatory care, and others.
| Report Attributes | Report Details |
|---|---|
| Report Name | Cardiac Monitoring & Cardiac Rhythm Management Devices Market |
| Market Size in 2023 | USD 15.89 Billion |
| Market Forecast in 2032 | USD 27.87 Billion |
| Growth Rate | CAGR of 6.44% |
| Number of Pages | 110 |
| Key Companies Covered | St. Jude Medical, Inc., GE Healthcare, Cardiac Science Corporation, Philips Healthcare, Mortara Instrument, Inc., Medtronic plc, Boston Scientific Corporation, and LivaNova PLC. The other players in the market include SCHILLER AG, Hill-Rom Holdings, Inc., Nihon Kohden Corporation, Abiomed, Inc., General Electric Company, Biotronik SE & Co. KG, Jarvik Heart, Inc., Koninklijke Philips N.V., Berlin Heart GmbH, and ReliantHeart Inc |
| Segments Covered | By Cardiac Monitoring Devices, By Cardiac Rhythm Management Devices, By End-User And By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
| Base Year | 2023 |
| Historical Year | 2018 - 2022 |
| Forecast Year | 2024 - 2032 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America is anticipated to dominate the global cardiac monitoring & cardiac rhythm management devices market in the near future owing to the increasing prevalence of heart failure & arrhythmia, the increasing aging population, and growing patient alertness regarding the accessibility of treatment choices. Asia-Pacific region is also expected to grow at a higher rate in the coming period in the market.
The major players in the cardiac monitoring & cardiac rhythm management devices market are:
The other players in the market include:
By Cardiac Monitoring Devices
By Cardiac rhythm management devices
By End-user
By Region
FrequentlyAsked Questions
These devices monitor heart activity and manage irregular heart rhythms. They include pacemakers, defibrillators, and cardiac monitors.
The global cardiac monitoring & cardiac rhythm management devices market is expected to be driven by the demand for continuous cardiac monitoring, rising heart disease cases, and adoption of remote and wearable monitoring devices.
According to study, the global cardiac monitoring & cardiac rhythm management devices market size was worth around USD 15.89 Billion in 2023 and is predicted to grow to around USD 27.87 Billion By 2032.
The global cardiac monitoring & cardiac rhythm management devices market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 6.44% during the forecast period from 2024-2032.
The global cardiac monitoring & cardiac rhythm management devices industry is projected to be challenged by Key challenges include data accuracy, device miniaturization, and cybersecurity for connected systems. Regulatory compliance and reimbursement pressures impact adoption rates.
The Opportunities include wearable monitors, remote patient management, and AI-based arrhythmia detection. Chronic disease prevalence and telecardiology drive demand will offer significant growth opportunities in the cardiac monitoring & cardiac rhythm management devices market.
Remote and wearable cardiac monitors; AI-based arrhythmia detection; cloud-enabled patient data analysis are the emerging trends and innovations impacting the cardiac monitoring & cardiac rhythm management devices market.
The global cardiac monitoring & cardiac rhythm management devices market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global cardiac monitoring & cardiac rhythm management devices market are; St. Jude Medical, Inc., GE Healthcare, Cardiac Science Corporation, Philips Healthcare, Mortara Instrument, Inc., Medtronic plc, Boston Scientific Corporation, and LivaNova PLC. The other players in the market include SCHILLER AG, Hill-Rom Holdings, Inc., Nihon Kohden Corporation, Abiomed, Inc., General Electric Company, Biotronik SE & Co. KG, Jarvik Heart, Inc., Koninklijke Philips N.V., Berlin Heart GmbH, and ReliantHeart Inc and others.
The report explores crucial aspects of the cardiac monitoring & cardiac rhythm management devices market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients